Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
Purdue Research Foundation
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
10 mars 2025 08h01 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., March 10, 2025 (GLOBE NEWSWIRE) -- Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral...
High-tech startup CrySyst provides quality-by-control solutions for pharmaceutical, fine chemical industries
03 mars 2025 08h15 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., March 03, 2025 (GLOBE NEWSWIRE) -- International process systems and operation experts have launched high-tech startup Crystallization Systems Technology Inc. (CrySyst) to...
Amplified Sciences earns CLIA certification for its first test to assess pancreatic cancer risk
19 févr. 2025 09h01 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, more accurate detection of challenging...
Emboa Medical creates, validates novel catheter to improve stroke patients’ outcomes
18 févr. 2025 09h01 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Emboa Medical Inc., a medical device startup, has mimicked a snake’s evolutionary advantage to improve the retrieval of blood clots that cause...
Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies
21 nov. 2024 09h24 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company that licenses innovations from Purdue Research Foundation, has developed a patent-pending antiviral...
Purdue innovations detect lead exposure faster, easier and with greater precision at the point of care
31 oct. 2024 09h57 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Exposure to lead can adversely impact people’s health in several ways. A Purdue University researcher in the College of Health and Human...
Biotech company Eradivir closes $10.25M Series A funding round to complete Phase 2a study of influenza therapeutic
25 sept. 2024 10h00 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round. The...
Biotech company Eradivir is developing lead drug EV25 to treat influenza
09 juil. 2024 14h24 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., July 09, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company, leverages small molecule targeting technology developed in Philip Low’s lab at Purdue University to...
From eureka moments to industry impact: Tillmann Kubis’ quantum code library
08 juil. 2024 10h59 HE
|
Purdue Research Foundation
WEST LAFAYETTE, IND., July 08, 2024 (GLOBE NEWSWIRE) -- You could talk to Tillmann Kubis for hours. His laid-back demeanor and desire for everyone to understand what he’s working on is so...
‘Like a hand fitting into a glove’: Purdue-engineered compound designed to treat drug-resistant acute myeloid leukemia
20 juin 2024 10h55 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., June 20, 2024 (GLOBE NEWSWIRE) -- Researchers at Purdue University’s College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute...